Literature DB >> 10359672

Sigmoidal kinetic model for two co-operative substrate-binding sites in a cytochrome P450 3A4 active site: an example of the metabolism of diazepam and its derivatives.

M Shou1, Q Mei, M W Ettore, R Dai, T A Baillie, T H Rushmore.   

Abstract

Cytochrome P450 3A4 (CYP3A4) plays a prominent role in the metabolism of a vast array of drugs and xenobiotics and exhibits broad substrate specificities. Most cytochrome P450-mediated reactions follow simple Michaelis-Menten kinetics. These parameters are widely accepted to predict pharmacokinetic and pharmacodynamic consequences in vivo caused by exposure to one or multiple drugs. However, CYP3A4 in many cases exhibits allosteric (sigmoidal) characteristics that make the Michaelis constants difficult to estimate. In the present study, diazepam, temazepam and nordiazepam were employed as substrates of CYP3A4 to propose a kinetic model. The model hypothesized that CYP3A4 contains two substrate-binding sites in a single active site that are both distinct and co-operative, and the resulting velocity equation had a good fit with the sigmoidal kinetic observations. Therefore, four pairs of the kinetic estimates (KS1, kalpha, KS2, kbeta, KS3, kdelta, KS4 and kgamma) were resolved to interpret the features of binding affinity and catalytic ability of CYP3A4. Dissociation constants KS1 and KS2 for two single-substrate-bound enzyme molecules (SE and ES) were 3-50-fold greater than KS3 and KS4 for a two-substrate-bound enzyme (SES), while respective rate constants kdelta and kgamma were 3-218-fold greater than kalpha and kbeta, implying that access and binding of the first molecule to either site in an active pocket of CYP3A4 can enhance the binding affinity and reaction rate of the vacant site for the second substrate. Thus our results provide some new insights into the co-operative binding of two substrates in the inner portions of an allosteric CYP3A4 active site.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10359672      PMCID: PMC1220319     

Source DB:  PubMed          Journal:  Biochem J        ISSN: 0264-6021            Impact factor:   3.857


  31 in total

1.  KINETICS OF REGULATORY ENZYMES. KINETIC ORDER OF THE YEAST DIPHOSPHOPYRIDINE NUCLEOTIDE ISOCITRATE DEHYDROGENASE REACTION AND A MODEL FOR THE REACTION.

Authors:  D E ATKINSON; J A HATHAWAY; E C SMITH
Journal:  J Biol Chem       Date:  1965-06       Impact factor: 5.157

2.  Modulation of rabbit and human hepatic cytochrome P-450-catalyzed steroid hydroxylations by alpha-naphthoflavone.

Authors:  G E Schwab; J L Raucy; E F Johnson
Journal:  Mol Pharmacol       Date:  1988-05       Impact factor: 4.436

Review 3.  Factors influencing the metabolism of diazepam.

Authors:  L Bertilsson; T A Baillie; J Reviriego
Journal:  Pharmacol Ther       Date:  1990       Impact factor: 12.310

Review 4.  The molecular biology of cytochrome P450s.

Authors:  F J Gonzalez
Journal:  Pharmacol Rev       Date:  1988-12       Impact factor: 25.468

5.  [Interaction of coumarin-hydroxylating cytochrome P-450coh from liver microsomes of mice induced by pyrazole with cytochrome b5].

Authors:  S A Usanov; P Honkakoski; M Lang; O Hanninen
Journal:  Biokhimiia       Date:  1990-06

6.  Human NADPH-P450 oxidoreductase: complementary DNA cloning, sequence and vaccinia virus-mediated expression and localization of the CYPOR gene to chromosome 7.

Authors:  S Yamano; T Aoyama; O W McBride; J P Hardwick; H V Gelboin; F J Gonzalez
Journal:  Mol Pharmacol       Date:  1989-07       Impact factor: 4.436

Review 7.  Enzymatic oxidation of xenobiotic chemicals.

Authors:  F P Guengerich
Journal:  Crit Rev Biochem Mol Biol       Date:  1990       Impact factor: 8.250

8.  Human P450PCN1: sequence, chromosome localization, and direct evidence through cDNA expression that P450PCN1 is nifedipine oxidase.

Authors:  F J Gonzalez; B J Schmid; M Umeno; O W Mcbride; J P Hardwick; U A Meyer; H V Gelboin; J R Idle
Journal:  DNA       Date:  1988-03

9.  Purification and characterization of six cytochrome P-450 isozymes from human liver microsomes.

Authors:  P P Wang; P Beaune; L S Kaminsky; G A Dannan; F F Kadlubar; D Larrey; F P Guengerich
Journal:  Biochemistry       Date:  1983-11-08       Impact factor: 3.162

10.  Cytochrome P450IIIA enzymes in rat liver microsomes: involvement in C3-hydroxylation of diazepam and nordazepam but not N-dealkylation of diazepam and temazepam.

Authors:  P E Reilly; D A Thompson; S R Mason; W D Hooper
Journal:  Mol Pharmacol       Date:  1990-05       Impact factor: 4.436

View more
  15 in total

1.  CYP2C9 genotype-dependent effects on in vitro drug-drug interactions: switching of benzbromarone effect from inhibition to activation in the CYP2C9.3 variant.

Authors:  Matthew A Hummel; Charles W Locuson; Peter M Gannett; Dan A Rock; Carrie M Mosher; Allan E Rettie; Timothy S Tracy
Journal:  Mol Pharmacol       Date:  2005-06-13       Impact factor: 4.436

2.  Participation of CYP2C8 and CYP3A4 in the N-demethylation of imatinib in human hepatic microsomes.

Authors:  Noelia Nebot; Severine Crettol; Fabrizio d'Esposito; Bruce Tattam; David E Hibbs; Michael Murray
Journal:  Br J Pharmacol       Date:  2010-11       Impact factor: 8.739

Review 3.  Modeling kinetics of subcellular disposition of chemicals.

Authors:  Stefan Balaz
Journal:  Chem Rev       Date:  2009-05       Impact factor: 60.622

4.  Steroid bioconjugation to a CYP3A4 allosteric site and its effect on substrate binding and coupling efficiency.

Authors:  Vanja Polic; Irina F Sevrioukova; Karine Auclair
Journal:  Arch Biochem Biophys       Date:  2018-06-26       Impact factor: 4.013

Review 5.  Role of P-glycoprotein in pharmacokinetics: clinical implications.

Authors:  Jiunn H Lin; Masayo Yamazaki
Journal:  Clin Pharmacokinet       Date:  2003       Impact factor: 6.447

Review 6.  A novel type of allosteric regulation: functional cooperativity in monomeric proteins.

Authors:  Ilia G Denisov; Stephen G Sligar
Journal:  Arch Biochem Biophys       Date:  2012-01-08       Impact factor: 4.013

7.  Numerical Methods for Modeling Enzyme Kinetics.

Authors:  Jaydeep Yadav; Ken Korzekwa; Swati Nagar
Journal:  Methods Mol Biol       Date:  2021

8.  Evaluation of modafinil as a perpetrator of metabolic drug-drug interactions using a model informed cocktail reaction phenotyping trial protocol.

Authors:  Angela Rowland; Madelé van Dyk; David Warncken; Arduino A Mangoni; Michael J Sorich; Andrew Rowland
Journal:  Br J Clin Pharmacol       Date:  2018-01-10       Impact factor: 4.335

9.  Energetics of heterotropic cooperativity between alpha-naphthoflavone and testosterone binding to CYP3A4.

Authors:  Arthur G Roberts; William M Atkins
Journal:  Arch Biochem Biophys       Date:  2007-04-02       Impact factor: 4.013

10.  QM/MM study of the active species of the human cytochrome P450 3A4, and the influence thereof of the multiple substrate binding.

Authors:  Dan Fishelovitch; Carina Hazan; Hajime Hirao; Haim J Wolfson; Ruth Nussinov; Sason Shaik
Journal:  J Phys Chem B       Date:  2007-11-17       Impact factor: 2.991

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.